Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
32.66
+0.80 (2.51%)
Aug 21, 2026, 10:20 AM EDT - Market open
Hims & Hers Health Revenue
Hims & Hers Health had revenue of $753.21M in the quarter ending June 30, 2026, with 38.25% growth. This brings the company's revenue in the last twelve months to $2.58B, up 28.04% year-over-year. In the year 2025, Hims & Hers Health had annual revenue of $2.35B with 59.00% growth.
Revenue (ttm)
$2.58B
Revenue Growth
+28.04%
P/S Ratio
2.88
Revenue / Employee
$1,055,738
Employees
2,442
Market Cap
7.62B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.35B | 871.12M | 59.00% |
| Dec 31, 2024 | 1.48B | 604.51M | 69.33% |
| Dec 31, 2023 | 872.00M | 345.08M | 65.49% |
| Dec 31, 2022 | 526.92M | 255.04M | 93.81% |
| Dec 31, 2021 | 271.88M | 123.12M | 82.77% |
| Dec 31, 2020 | 148.76M | 66.20M | 80.18% |
| Dec 31, 2019 | 82.56M | 55.88M | 209.45% |
| Dec 31, 2018 | 26.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Elanco Animal Health | 5.02B |
| Dr. Reddy's Laboratories | 3.50B |
| Neurocrine Biosciences | 3.37B |
| Amneal Pharmaceuticals | 3.12B |
| Alkermes | 1.67B |
| Lantheus Holdings | 1.56B |
| Indivior Pharmaceuticals | 1.33B |
| Kiniksa Pharmaceuticals International, | 840.85M |
HIMS News
- 2 days ago - Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (HIMS) - Newsfile Corp
- 3 days ago - Hims & Hers CEO says FTC lawsuit misunderstands how the company works - CNBC
- 8 days ago - As Hims prepares for peptides launch, Wall Street cautious on prospects this year - Reuters
- 8 days ago - Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (NYSE: HIMS) - PRNewsWire
- 9 days ago - Hims & Hers Stock (HIMS) Slides as GLP-1 Push Swallows Profits and Widens Q2 Loss - TipRanks
- 10 days ago - HIMS Stock Sinks on Earnings Miss and Margin Pressure; Analysts Divided - TipRanks
- 10 days ago - Hims & Hers shares slide as costly weight-loss push squeezes margins - Reuters
- 10 days ago - AST SpaceMobile, Intel, On, Hims, and More Stocks That Explain Today's Market - Barrons